In contemporary management, the most pertinent example illustrating the impact of genomic profiling on breast cancer surgery is the screening for pathogenic variants of the breast cancer gene 1 (BRCA1) and/or 2 (BRCA2). Here, BRCA2 is linked to breast carcinoma.